Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Innehåll tillhandahållet av Proactive Investors. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Proactive Investors eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !
Gå offline med appen Player FM !
Monogram Technologies Announces Collaboration with Shalby Limited for Multicenter Clinical Trial
MP3•Episod hem
Manage episode 434033521 series 2891889
Innehåll tillhandahållet av Proactive Investors. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Proactive Investors eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Monogram Technologies CEO Benjamin Sexson joined Steve Darling from Proactive to announce a strategic collaboration with Shalby Limited, a global multi-specialty hospital chain and one of India's leading orthopaedic hospital groups. This partnership will focus on conducting a multicenter clinical trial aimed at demonstrating the safety and effectiveness of Monogram's mBȏs TKA System for joint replacement. Sexson explained that under this collaboration, Shalby will enroll patients across various sites in India, where surgeons will evaluate the mBȏs TKA System in conjunction with the Consensus CKS implant. The Consensus CKS implant is considered substantially equivalent to Monogram's mPress implants for regulatory purposes. Monogram has been actively engaged with the FDA, receiving feedback on their Clinical Investigational Plan during February 2024 Presubmission Communications. The company has incorporated this feedback into its 510(k) application, which has successfully passed the FDA Administrative Review. An interesting aspect of this collaboration is the potential post-trial transfer of a robot to the Shalby hospital system under specific conditions, as both companies explore further opportunities for collaboration. #proactiveinvestors #monogramtechnologiesin #nasdaq #mgrm #surgery #jointreplacement #RoboticSurgery #OrthopedicInnovation #KneeReplacement #MedicalTechnology #FDAApproval #SurgicalRobots #BenjaminSexson #HealthcareTech #ClinicalTrials #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
607 episoder
MP3•Episod hem
Manage episode 434033521 series 2891889
Innehåll tillhandahållet av Proactive Investors. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Proactive Investors eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
Monogram Technologies CEO Benjamin Sexson joined Steve Darling from Proactive to announce a strategic collaboration with Shalby Limited, a global multi-specialty hospital chain and one of India's leading orthopaedic hospital groups. This partnership will focus on conducting a multicenter clinical trial aimed at demonstrating the safety and effectiveness of Monogram's mBȏs TKA System for joint replacement. Sexson explained that under this collaboration, Shalby will enroll patients across various sites in India, where surgeons will evaluate the mBȏs TKA System in conjunction with the Consensus CKS implant. The Consensus CKS implant is considered substantially equivalent to Monogram's mPress implants for regulatory purposes. Monogram has been actively engaged with the FDA, receiving feedback on their Clinical Investigational Plan during February 2024 Presubmission Communications. The company has incorporated this feedback into its 510(k) application, which has successfully passed the FDA Administrative Review. An interesting aspect of this collaboration is the potential post-trial transfer of a robot to the Shalby hospital system under specific conditions, as both companies explore further opportunities for collaboration. #proactiveinvestors #monogramtechnologiesin #nasdaq #mgrm #surgery #jointreplacement #RoboticSurgery #OrthopedicInnovation #KneeReplacement #MedicalTechnology #FDAApproval #SurgicalRobots #BenjaminSexson #HealthcareTech #ClinicalTrials #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
607 episoder
Alla avsnitt
×Välkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.